Transcat, Inc. (NASDAQ:TRNS – Free Report) – Investment analysts at HC Wainwright dropped their Q4 2025 earnings per share estimates for Transcat in a report released on Wednesday, October 30th. HC Wainwright analyst S. Buck now expects that the scientific and technical instruments company will post earnings of $0.48 per share for the quarter, down from their previous forecast of $0.63. HC Wainwright has a “Buy” rating and a $156.00 price target on the stock. The consensus estimate for Transcat’s current full-year earnings is $2.06 per share.
Transcat (NASDAQ:TRNS – Get Free Report) last posted its quarterly earnings data on Monday, October 28th. The scientific and technical instruments company reported $0.35 EPS for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.12). Transcat had a return on equity of 7.62% and a net margin of 6.63%. The firm had revenue of $67.83 million during the quarter, compared to the consensus estimate of $70.30 million. During the same period in the prior year, the firm posted $0.41 EPS. The firm’s quarterly revenue was up 8.0% on a year-over-year basis.
Check Out Our Latest Report on Transcat
Transcat Trading Down 0.2 %
Shares of Transcat stock opened at $95.41 on Thursday. Transcat has a 52 week low of $84.45 and a 52 week high of $147.12. The stock has a market cap of $873.00 million, a PE ratio of 48.19 and a beta of 0.67. The company’s 50-day moving average price is $121.71 and its two-hundred day moving average price is $121.89.
Institutional Trading of Transcat
Several large investors have recently added to or reduced their stakes in TRNS. Conestoga Capital Advisors LLC boosted its position in Transcat by 17.9% during the 3rd quarter. Conestoga Capital Advisors LLC now owns 907,191 shares of the scientific and technical instruments company’s stock worth $109,561,000 after acquiring an additional 137,830 shares during the period. Hood River Capital Management LLC lifted its position in shares of Transcat by 21.6% in the second quarter. Hood River Capital Management LLC now owns 196,838 shares of the scientific and technical instruments company’s stock worth $23,558,000 after purchasing an additional 34,947 shares in the last quarter. Wealth Enhancement Advisory Services LLC boosted its holdings in shares of Transcat by 28.8% during the third quarter. Wealth Enhancement Advisory Services LLC now owns 79,303 shares of the scientific and technical instruments company’s stock worth $9,577,000 after purchasing an additional 17,743 shares during the period. Raymond James & Associates grew its position in Transcat by 157.2% during the third quarter. Raymond James & Associates now owns 20,651 shares of the scientific and technical instruments company’s stock valued at $2,494,000 after purchasing an additional 12,622 shares in the last quarter. Finally, Janus Henderson Group PLC increased its stake in Transcat by 208.3% in the 1st quarter. Janus Henderson Group PLC now owns 10,297 shares of the scientific and technical instruments company’s stock valued at $1,147,000 after buying an additional 6,957 shares during the period. 98.34% of the stock is owned by institutional investors and hedge funds.
About Transcat
Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.
Recommended Stories
- Five stocks we like better than Transcat
- What does consumer price index measure?
- Energy Vault Soars 100%: CEO Shares Why in MarketBeat Exclusive
- How to Read Stock Charts for Beginners
- Meta’s Q3 Earnings Beat—Is This Dip a Golden Entry Opportunity?
- What Are Dividend Challengers?
- Top Nuclear Stocks Thriving on Soaring Energy Demand
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.